510(k) Report

510(k) · Cleared

Cleared

OneTouch Delica Plus Lancing System

K221546510(k) TraditionalCleared Aug 23, 202288-day reviewClass II21 CFR 878.4850

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Asahi Polyslider Co., Ltd. · QRL Multiple Use Blood Lancet For Single Patient Use Only

Cleared on Aug 23, 2022 as substantially equivalent to K214022 (Roche Diabetes Care, Inc., 2022) after an 88-day review. Its family tree reaches back 2 generations to 1981.

Decided
Aug 23, 2022
Review
88 days
Class
Class II
Product code
QRL
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K810075 (1981). No later device cites it as a predicate yet.

  1. Root · 2 generations backK810075 AutoclixBiodynamics Corp. · 1981
  2. 1 generation backK214022 Accu-Chek Softclix Blood Lancing SystemRoche Diabetes Care, Inc. · 2022
  3. This deviceK221546 OneTouch Delica Plus Lancing SystemAsahi Polyslider Co., Ltd. · 2022
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K810075AutoclixBiodynamics Corp.1981—
−1K214022Accu-Chek Softclix Blood Lancing SystemRoche Diabetes Care, Inc.2022—
0 (this device)K221546OneTouch Delica Plus Lancing SystemAsahi Polyslider Co., Ltd.2022—
FIG. 1 — Lineage of K221546, 1981–2022Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QRL? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new QRL device

  1. #1 K214022 Accu-Chek Softclix Blood Lancing Systemscore 38.9 · 1 generation · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K214022Accu-Chek Softclix Blood Lancing System
Summary page 4
…General & Plastic Surgery 5. Legally Marketed Predicate Device Device name: Accu-Chek Softclix Blood Lancing System 510(k) number: K214022 Manufacturer: Roche Diabetes Care, Inc. 6. Indication for Use Statement The OneTouch® Delica® Plus lancets ar…
Roche Diabetes Care, Inc.2022—

Also cleared against K214022: 11 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 41 years and passes through 3 companies; a new generation was cleared every 41.0 years on median.
  • None of the 2 ancestors has a recall.
  • 11 other devices also cite its predicate K214022.

How does its category compare?

All QRL devices

QRL Multiple Use Blood Lancet For Single Patient Use Only: FDA decisions, review times, recalls and adverse event reports over 20 years. 2022, this device’s year, is highlighted.

FDA decisions per year · QRL

2in 2025

2022: 172023: 32024: 22025: 22026 (partial year): 3
2007high 17 (2022) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QRL

155in 2023

2022: 91 days median2023: 155 days median2026 (partial year): 54 days median
2007high 155 (2023) · low 91 (2022)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · QRL

1in 2025

2025: 1
2007high 1 (2025) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · QRL

133in 2025

2022: 12023: 32024: 72025: 133
2007high 133 (2025) · low 0 (2007)2025

MAUDE reports naming product code QRL, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
2022179101
2023315503
20242—07
20252—1133
20263540—

What is it indicated for?

The OneTouch@ Delica@ Plus lancets are sterile, single use devices that have been designed for single patient use by lay users in a home or general environment. Their intended use is for performing skin punctures on patients for the purpose of obtaining capillary blood samples from the fingertips. The OneTouch Delica Plus lancets are compatible with the single patient use OneTouch@ Delica@ Plus lancing device.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K221546: OneTouch Delica Plus Lancing System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K221546

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026